Anna Protopapas insider trades

Open-market stock purchases and sales by Anna Protopapas, Unknown at Nuvalent, Inc, from SEC Form 4 filings since Apr 28, 2015.

Recent trades

DateStockTradeValue
Jun 16, 2026NUVL Nuvalent, IncBought (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$22.3K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$436K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$171K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$2.7M
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$714K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$88
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$1.6K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$47.6K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$1.8M
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$21.9K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$1.4M
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$1.7M
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$124K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$116K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$536K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$29K
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)—
Jan 6, 2026MRSN Mersana Therapeutics, IncSold (not open market)$152K

Companies traded

  • NUVL Nuvalent, Inc: 1 sale, last Jun 16, 2026
  • MRSN Mersana Therapeutics, Inc: 7 sales, last Jan 6, 2026
  • DRNA Dicerna Pharmaceuticals Inc: other filings, last Jun 3, 2021
  • BIVV Bioverativ Inc: other filings, last Mar 8, 2018
  • ARIA Ariad Pharmaceuticals Inc: other filings, last Feb 16, 2017

Get free alerts when Anna Protopapas files a new trade →